The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
Open accessAbstract
Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair. In addition, antigens present in necrotic cells can sometimes provoke a specific immune response and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection. In the mouse, the CD8alpha+ subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8+ T cells against cell-associated antigens. Here we show that CD8alpha+ dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin, to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8+ dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of caspases, a specific class of cysteine proteases has multiple effects on the immunogenicity of cell death 56”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis has traditionally been considered merely as an accidental, uncontrolled form of cell death that only occurs in pathological circumstances.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“There are several distinct subtypes of apoptosis that, although morphologically similar, can be triggered through different biochemical routes (for example, through the intrinsic or the extrinsic pathway or with or without caspase activation).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Autophagic cell death occurs in the absence of chromatin condensation but is accompanied by massive autophagic vacuolization of the cytoplasm.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Apoptosis is accompanied by rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), few or no ultrastructural modifications of cytoplasmic organelles, and plasma membrane blebbing but cell integrity is maintained until the final stages of the process.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Furthermore, the apparent uniformity of apoptotic cell death may conceal heterogeneous functional aspects, such as whether or not dying apoptotic cells are recognized by the immune system 56.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“CLeC9A has been shown to recognize necrotic cells and induce the cross-presentation of dead cell-associated antigens to CD8+ T cells.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
In the citing paper
“Therefore, it may be involved in regulating sterile immune responses, although the specific ligand recognized in this case is still unknown73,75.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 750
Decoding immunogenic cell death from a dendritic cell perspective
Janssens, S., Rennen, S., & Agostinis, P. (2023) · Immunological Reviews · doi:10.1111/imr.13301 · Cited by 106
Lehmann, C. H. K., Heger, L., Heidkamp, G. F., Barańska, A., Lühr, J. J., Hoffmann, A., & Dudziak, D. (2016) · Vaccines · doi:10.3390/vaccines4020008 · Cited by 95
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Baldin, A. V., Savvateeva, L. V., Bazhin, A. V., & Zamyatnin, A. A. (2020) · Cancers · doi:10.3390/cancers12030590 · Cited by 91
Targeting Dendritic Cells in vivo for Cancer Therapy
Caminschi, I., Maraskovsky, E., & Heath, W. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00013 · Cited by 91
Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
Shields, A. M., Panayi, G. S., & Corrigall, V. M. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04433.x · Cited by 90
Regulation of Antigen Export to the Cytosol During Cross-Presentation
Gros, M., & Amigorena, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00041 · Cited by 90
Boosting antibody responses by targeting antigens to dendritic cells
Caminschi, I., & Shortman, K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.10.007 · Cited by 89
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
Meng, M.-B., Wang, H.-H., Cui, Y.-L., Wu, Z.-Q., Shi, Y., Zaorsky, N. G., Deng, L., Yuan, Z., Lü, Y., & Wang, P. (2016) · Oncotarget · doi:10.18632/oncotarget.10548 · Cited by 91
Syk Signaling in Dendritic Cells Orchestrates Innate Resistance to Systemic Fungal Infection
Whitney, P. G., Bär, E., Osorio, F., Rogers, N. C., Schraml, B. U., Deddouche, S., LeibundGut‐Landmann, S., & Sousa, C. R. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004276 · Cited by 94
Self-citationSensing of cell death by myeloid C-type lectin receptors
Sancho, D., & Sousa, C. R. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.007 · Cited by 93
Self-citationPollitt, A. Y., Grygielska, B., Leblond, B., Désiré, L., Eble, J. A., & Watson, S. P. (2010) · Blood · doi:10.1182/blood-2009-12-257212 · Cited by 88
Li, J., Ahmet, F., Sullivan, L. C., Brööks, A. G., Kent, S. J., Rose, R. D., Salazar, A. Μ., Sousa, C. R. E., Shortman, K., Lahoud, M. H., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201445127 · Cited by 87
Self-citationPrerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Hannani, D., Sistigu, A., Kepp, O., Galluzzi, L., Kroemer, G., & Zitvogel, L. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325d4d · Cited by 88
CLEC‐2 signaling via Syk in myeloid cells can regulate inflammatory responses
Mourão‐Sá, D., Robinson, M. J., Zelenay, S., Sancho, D., Chakravarty, P., Larsen, R., Plantinga, M., van Rooijen, N., Soares, M. P., Lambrecht, B. N., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141641 · Cited by 88
Self-citationvan Dinther, D., Stolk, D. A., van de Ven, R., van Kooyk, Y., de Gruijl, T. D., & den Haan, J. M. M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr0217-059rr · Cited by 88
Lai, J.-J., Cruz, F. M., & Rock, K. L. (2020) · Immunity · doi:10.1016/j.immuni.2019.11.013 · Cited by 85
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 94
Hanč, P., Fujii, T., Iborra, S., Yamada, Y., Huotari, J., Schulz, O., Ahrens, S., Kjær, S., Way, M., Sancho, D., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.009 · Cited by 86
Self-citationTargeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
Tullett, K. M., Rojas, I. L., Minoda, Y., Tan, P. S., Zhang, J., Smith, C., Khanna, R., Shortman, K., Caminschi, I., Lahoud, M. H., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87102 · Cited by 86
Gallizioli, M., Miró‐Mur, F., Otxoa-de-Amezaga, A., Cugota, R., Salas-Perdomo, A., Justicia, C., Brait, V. H., Ruíz-Jaén, F., Arbaizar‐Rovirosa, M., Pedragosa, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108291 · Cited by 85
Self-citationRestoring tumor immunogenicity with dendritic cell reprogramming
Zimmermannová, O., Ferreira, A. G., Ascic, E., Santiago, M. V., Kurochkin, I., Hansen, M., Met, Ö., Caiado, I., Shapiro, I. E., Michaux, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add4817 · Cited by 89
Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation
Chistiakov, D. A., Sobenin, I. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.12.010 · Cited by 85
Macrophages Discriminate Glycosylation Patterns of Apoptotic Cell-derived Microparticles
Bilyy, R. O., Shkandina, T., Tomin, A., Munoz, L. E., Franz, S., Antonyuk, V., Kit, Y. Y., Zirngibl, M., Fürnrohr, B. G., Janko, C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.273144 · Cited by 83
Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells
Hou, W., Gibbs, J. S., Lu, X., Brooke, C. B., Roy, D., Modlin, R. L., Bennink, J. R., & Yewdell, J. W. (2012) · Blood · doi:10.1182/blood-2011-09-379479 · Cited by 83
The role of cDC1s in vivo: CD8 T cell priming through cross-presentation
Theisen, D. J., & MURPHY, K. M. M. (2017) · F1000Research · doi:10.12688/f1000research.9997.1 · Cited by 86
Dendritic cell targeted vaccines: Recent progresses and challenges
Chen, P., Liu, X., Sun, Y., Zhou, P., Wang, Y., & Zhang, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1105415 · Cited by 81
B-cell selection and the development of autoantibodies
Giltiay, N. V., Chappell, C. P., & Clark, E. A. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3918 · Cited by 87
The dendritic cell–tumor cross-talk in cancer
Ma, Y., Aymeric, L., Locher, C., Kroemer, G., & Zitvogel, L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.09.008 · Cited by 80
Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage
Heger, L., Hofer, T. P. J., Bigley, V., de Vries, I. J. M., Dalod, M., Dudziak, D., & Ziegler‐Heitbrock, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559166 · Cited by 80
Langerin functions as an antiviral receptor on Langerhans cells
Vlist, M., & Geijtenbeek, T. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.32 · Cited by 77
RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells
Kretzer, N. M., Theisen, D. J., Tussiwand, R., Briseño, C. G., Grajales‐Reyes, G. E., Wu, X., Durai, V., Albring, J. C., Bagadia, P., Murphy, T. L., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160597 · Cited by 84
Li, S., Wan, J., Anderson, W. H., Sun, H., Zhang, H., Peng, X., Yu, Z., Wang, T., Yan, X., & Smith, W. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.036 · Cited by 77
Designing CD8+ T cell vaccines: it's not rocket science (yet)
Yewdell, J. W. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.002 · Cited by 77
Molecular determinants of sterile inflammation
Kono, H., Onda, A., & Yanagida, T. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.004 · Cited by 77
Spel, L., Boelens, J. J., Nierkens, S., & Boes, M. L. (2013) · OncoImmunology · doi:10.4161/onci.26403 · Cited by 77
Zeng, R., Bscheider, M., Lahl, K., Lee, M. K., & Butcher, E. C. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.50 · Cited by 75
Control of Dendritic Cell Function Within the Tumour Microenvironment
Hari‐Gupta, Y., Khanom, A., & Acton, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.733800 · Cited by 73
Danger-Associated Molecular Patterns and Danger Signals in Idiopathic Pulmonary Fibrosis
Ellson, C. D., Dunmore, R., Hogaboam, C. M., Sleeman, M. A., & Murray, L. A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0366tr · Cited by 74
Srinivasan, N., Gordon, O., Ahrens, S., Franz, A., Deddouche, S., Chakravarty, P., Phillips, D., Yunus, A. A., Rosen, M. K., Valente, R. S., et al. (2016) · eLife · doi:10.7554/elife.19662 · Cited by 69
Self-citationHarnessing dendritic cells in cancer
Apétoh, L., Locher, C., Ghiringhelli, F., Kroemer, G., & Zitvogel, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.003 · Cited by 79
Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors
Iborra, S., & Sancho, D. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.09.013 · Cited by 74
Self-citationEnemy at the gates: dendritic cells and immunity to mucosal pathogens
Soloff, A. C., & Barratt‐Boyes, S. M. (2010) · Cell Research · doi:10.1038/cr.2010.94 · Cited by 67
Caronni, N., Piperno, G. M., Simoncello, F., Romano, O., Vodret, S., Yanagihashi, Y., Dress, R. J., Dutertre, C., Bugatti, M., Bourdeley, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22535-z · Cited by 70
Janela, B., Patel, A. A., Lau, M. C., Goh, C. C., Msallam, R., Kong, W. T., Fehlings, M., Hubert, S., Lum, J., Simoni, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.001 · Cited by 75
Aligning bona fide dendritic cell populations across species
Dutertre, C., Wang, L., & Ginhoux, F. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.08.006 · Cited by 69
BDCA3+CLEC9A+ human dendritic cell function and development
van der Aa, E., van Montfoort, N., & Woltman, A. M. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.05.016 · Cited by 76
Chemokines: A New Dendritic Cell Signal for T Cell Activation
Thaiss, C. A., Semmling, V., Franken, L., Wagner, H., & Kurts, C. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00031 · Cited by 78
Therapeutic Targeting of Syk in Autoimmune Diabetes
Colonna, L., Catalano, G., Chew, C., D’Agati, V. D., Thomas, J. W., Wong, F. S., Schmitz, J., Masuda, E. S., Reizis, B., Tarakhovsky, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000983 · Cited by 68
Development of antigen cross-presentation capacity in dendritic cells
Dresch, C., Leverrier, Y., Marvel, J., & Shortman, K. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.009 · Cited by 67
Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection
Kim, T. H., & Lee, H. K. (2014) · Immune Network · doi:10.4110/in.2014.14.3.128 · Cited by 68
Kawano, M., Tanaka, K., Itonaga, I., Iwasaki, T., Miyazaki, M., Ikeda, S., & Tsumura, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.4175 · Cited by 67
Crosstalk between the immune receptors and gut microbiota
Mu, C., Yang, Y., & Zhu, W. (2015) · Current Protein & Peptide Science · doi:10.2174/1389203716666150630134356 · Cited by 66
Wüthrich, M., Wang, H., Li, M., Lerksuthirat, T., Hardison, S. E., Brown, G. D., & Klein, B. S. (2015) · European Journal of Immunology · doi:10.1002/eji.201545591 · Cited by 66
Pathways of MHC I cross-presentation of exogenous antigens
Cruz, F. M., Chan, A., & Rock, K. L. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101729 · Cited by 66
Dendritic Cells Promote Pancreatic Viability in Mice With Acute Pancreatitis
Bedrosian, A. S., Nguyen, A. H., Hackman, M., Connolly, M. K., Malhotra, A., Ibrahim, J., Cieza-Rubio, N. E., Henning, J. R., Barilla, R., Rehman, A. U., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.033 · Cited by 66
Innate and intrinsic antiviral immunity in skin
Kawamura, T., Ogawa, Y., Aoki, R., & Shimada, S. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.05.004 · Cited by 67
The confluence of radiotherapy and immunotherapy
Burnette, B., Fu, Y., & Weichselbaum, R. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00143 · Cited by 65
Patel, V. I., Booth, J. L., Duggan, E. S., Cate, S. J., White, V. L., Hutchings, D., Kovats, S., Burian, D. M., Dozmorov, M. G., & Metcalf, J. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600777 · Cited by 68
Lança, T., Ungerbäck, J., Silva, C. D., Joeris, T., Ahmadi, F., Vandamme, J., Svensson, M., Mowat, A. M., Kotarsky, K., Sigvardsson, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.006 · Cited by 64
Widenmeyer, M., Shebzukhov, Y. V., Haen, S. P., Schmidt, D., Clasen, S., Boss, A., Kuprash, D. V., Nedospasov, S. A., Stenzl, A., Aebert, H., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25601 · Cited by 64
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
Yan, Z., Wu, Y., Du, J., Li, G., Wang, S., Cao, W., Zhou, X., Wu, C., Zhang, D., Jing, X.-L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9624 · Cited by 65
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Bödder, J., Zahan, T., van Slooten, R., Schreibelt, G., de Vries, I. J. M., & Flórez‐Grau, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.631713 · Cited by 67
Partial role of TLR4 as a receptor responding to damage-associated molecular pattern
Lee, K., & Seong, S. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.05.006 · Cited by 63
Criteria for Dendritic Cell Receptor Selection for Efficient Antibody-Targeted Vaccination
Reuter, A., Panozza, S. E., Macri, C., Dumont, C., Li, J., Liu, H., Segura, É., Vega‐Ramos, J., Gupta, N., Caminschi, I., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402535 · Cited by 62
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 63
Retroviral Retention Activates a Syk-Dependent HemITAM in Human Tetherin
Galão, R. P., Pickering, S., Curnock, R., & Neil, S. J. D. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.005 · Cited by 62
Necrosis: C-Type Lectins Sense Cell Death
Cambi, A., & Figdor, C. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.032 · Cited by 61
Quintana, E., Fernández, A., Velasco, P., de Andrés, B., Liste, I., Sancho, D., Gaspar, M.-L., & Cano, E. (2015) · Glia · doi:10.1002/glia.22889 · Cited by 62
Self-citationInhibitory C-type lectin receptors in myeloid cells
Redelinghuys, P., & Brown, G. D. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.10.005 · Cited by 62
Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo
Matheoud, D., Perié, L., Hoeffel, G., Vimeux, L., Parent, I., Marañón, C., Bourdoncle, P., Rénia, L., Prévost‐Blondel, A., Lucas, B., et al. (2010) · Blood · doi:10.1182/blood-2009-11-255935 · Cited by 69
Davies, S. P., Reynolds, G. M., & Stamataki, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00044 · Cited by 61
Fu, X., Zeng, H., Zhao, J., Zhou, G., Zhou, H., Zhuang, J., Xu, C., Li, J., Peng, Y., Cao, Y., et al. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00889-2 · Cited by 61
The diverse roles of C-type lectin-like receptors in immunity
Scur, M., Parsons, B., Dey, S., & Makrigiannis, A. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126043 · Cited by 62
Lang, R., Schoenen, H., & Desel, C. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.005 · Cited by 60
Mattiuz, R., Brousse, C., Ambrosini, M., Cancel, J.-C., Bessou, G., Mussard, J., Sanlaville, A., Caux, C., Bendriss‐Vermare, N., Valladeau‐Guilemond, J., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1305 · Cited by 61
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
Lu, Y., Luo, X., Wang, Q., Chen, J., Zhang, X., Li, Y., Chen, Y., Li, X., & Han, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.862741 · Cited by 59
Robles‐Vera, I., Jarit-Cabanillas, A., Brandi, P., Martínez‐López, M., Martínez-Cano, S., Rodrigo-Tapias, M., Femenía-Muiña, M., Redondo‐Urzainqui, A., Nuñez, V., González‐Correa, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.12.012 · Cited by 64
Self-citationAn Updated View of the Intracellular Mechanisms Regulating Cross-Presentation
Nair-Gupta, P., & Blander, J. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00401 · Cited by 63
The promise of glycomics, glycan arrays and carbohydrate-based vaccines
Lepenies, B., & Seeberger, P. H. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903292663 · Cited by 61
Joeris, T., Gómez‐Casado, C., Holmkvist, P., Tavernier, S. J., Silva-Sánchez, A., Klotz, L., Randall, T. D., Mowat, A. M., Kotarsky, K., MALISSEN, B., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd3774 · Cited by 58
Behar, S. M., Martin, C. J., Nunes-Alves, C., Divangahi, M., & Remold, H. G. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.03.002 · Cited by 57
The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity
Malamud, M., & Brown, G. D. (2024) · EMBO Reports · doi:10.1038/s44319-024-00296-2 · Cited by 58
Heger, L., Hatscher, L., Liang, C., Lehmann, C. H. K., Amon, L., Lühr, J. J., Kaszubowski, T., Nzirorera, R., Schaft, N., Dörrie, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300343120 · Cited by 54
Increasing the efficacy of tumor cell vaccines by enhancing cross priming
Andersen, B. M., & Ohlfest, J. R. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.012 · Cited by 56
Human dendritic cell subsets in vaccination
Palucka, K., & Banchereau, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.001 · Cited by 57
Molecular Recognition of Paired Receptors in the Immune System
Kuroki, K., Furukawa, A., & Maenaka, K. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00429 · Cited by 56
A Dual Role of Type I Interferons in Antitumor Immunity
Zhou, L., Zhang, Y., Wang, Y., Zhang, M., Sun, W., Dai, T., Wang, A., Wu, X., Zhang, S., Wang, S., et al. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900237 · Cited by 62
Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation
Mortimer, P. M., McIntyre, S., & Thomas, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733918 · Cited by 63
Narayanan, P., Lapteva, N., Seethammagari, M. R., Levitt, J. M., Slawin, K. M., & Spencer, D. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44327 · Cited by 55
Boozari, B., Mundt, B., Woller, N., Strüver, N., Gürlevik, E., Schache, P., Kloos, A., Knocke, S., Manns, M. P., Wirth, T. C., et al. (2010) · Gut · doi:10.1136/gut.2009.196519 · Cited by 55
Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
Matsuo, K., Yoshie, O., Kitahata, K., Kamei, M., Hara, Y., & Nakayama, T. (2021) · Cancers · doi:10.3390/cancers13102495 · Cited by 54
C-type lectins and extracellular vesicles in virus-induced NETosis
Sung, P., & Hsieh, S.-L. E. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00741-7 · Cited by 55
Strategies to overcome DC dysregulation in the tumor microenvironment
Mestrallet, G., Sone, K., & Bhardwaj, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980709 · Cited by 56
Mattiuz, R., Wohn, C., Ghilas, S., Ambrosini, M., Alexandre, Y. O., Sanchez, C., Fries, A., Manh, T. V., MALISSEN, B., Dalod, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02805 · Cited by 55
Priego, N., de Pablos-Aragoneses, A., Perea-García, M., Pieri, V., Hernández-Oliver, C., Álvaro‐Espinosa, L., Rojas, A., Sánchez, O., Steindl, A., Caleiras, E. J., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0134 · Cited by 54
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
Kim, Y., Clements, D. R., Sterea, A. M., Jang, H. G., Gujar, S. A., & Lee, P. C. (2015) · Viruses · doi:10.3390/v7122953 · Cited by 53
Ferroptosis-mediated immune responses in cancer
Qi, D., & Peng, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188365 · Cited by 53
pH-dependent recognition of apoptotic and necrotic cells by the human dendritic cell receptor DEC205
Cao, L., Shi, X., Chang, H., Zhang, Q., & He, Y. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505924112 · Cited by 52
Blanco-Menéndez, N., del Fresno, C., Fernandes, S. R. M., Calvo, E., Conde‐Garrosa, R., Kerr, W. G., & Sancho, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402874 · Cited by 52
Self-citationCueto, F. J., del Fresno, C., & Sancho, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03146 · Cited by 54
Self-citation
Metadata
- Authors
- Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martínez, D., Hernanz-Falcón, P., Rosewell, I., & Sousa, C. R. E.
- Affiliations
- The Honourable Society of Lincoln's Inn (GB)
- Cancer Research UK (GB)
- Corresponding author
- Sousa, Caetano Reis e
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7240
- Pages
- 899-903
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2671489
- OpenAlex
- W2136883776
- Cited by
- 750
- References
- 27
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 31 · 2023: 44 · 2022: 45 · 2021: 39 · 2020: 44 · 2019: 38 · 2018: 37 · 2017: 30 · 2016: 47 · 2015: 49 · 2014: 54 · 2013: 55 · 2012: 61
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cancer Research UK (A3598)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CLEC9A, DNGR-1, C-type lectin receptors, dendritic cells, CD8α+ dendritic cells, necrosis, cross-presentation, Syk, immunogenicity, tissue repair, inflammation, allograft rejection, tumor rejection
- MeSH terms
- Animals, Cells, Cultured, Dendritic Cells, Humans, Ligands, Necrosis, Phagocytosis, Receptors, Immunologic, Receptors, Mitogen, Signal Transduction, CD8 Antigens, CD8-Positive T-Lymphocytes, Lectins, C-Type, Cross-Priming, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
